Relapsed High Grade B-cell Lymphoma (HGBCL)

Drug	Drug Name	Drug Description
DB13915	Axicabtagene ciloleucel	A CAR T-cell therapy used to treat adults with large B-cell lymphomas and follicular lymphoma.
DB16222	Loncastuximab tesirine	An antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas.

Drug	Drug Name	Target	Type
DB13915	Axicabtagene ciloleucel	B-lymphocyte antigen CD19	target
DB16222	Loncastuximab tesirine	B-lymphocyte antigen CD19	target
DB16222	Loncastuximab tesirine	P-glycoprotein 1	transporter
DB16222	Loncastuximab tesirine	Cytochrome P450 3A4	enzyme
DB16222	Loncastuximab tesirine	Cytochrome P450 3A5	enzyme

Drug	Drug Name	Phase	Status	Count